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	 What	is	the	best	nonsurgical	
therapy	for	pelvic	organ	prolapse?
	 Pelvic floor muscle training
 (PFMT)	 and	 pessaries	 are	 equally	
effective	 in	 treating	 symptoms	 of	 pelvic	
organ	 prolapse	 (POP).	 PFMT	 transiently	
improves	patient	 satisfaction	and	 reduces	
urinary	 incontinence	 more	 than	 pes-
saries	 do	 (strength	 of	 recommendation	
[SOR]:	 B, a	 randomized	 controlled	 trial	
[RCT]).
PFMT	moderately	 improves	prolapse	
symptoms	and	severity,	especially	follow-
ing	 6	 months	 of	 supervised	 intervention	
(SOR:	B, a	 systematic	 review	 of	 random-
ized	trials	with	some	methodologic	flaws).
Two	pessaries	(ring	with	support	and	
Gellhorn)	reduce	symptoms	in	as	many	as	
60%	of	 patients	 (SOR:	B,	 a	 systematic	 re-
view	of	randomized	trials).
Untreated	 postmenopausal	 women	
with	 mild	 grades	 of	 uterine	 prolapse	 are	
unlikely	to	develop	more	severe	prolapse;	
25%	to	50%	improve	spontaneously	(SOR:	
C, a	prospective	 cohort	 study	with	meth-
odologic	flaws).
Evidence summary
A	 2010	 multicenter	 RCT	 with	 445	 women	
(mean	age	49.8	years)	compared	PFMT,	pes-
sary	 use,	 and	 combined	 treatment.1	 Inves-
tigators	 used	 the	 Patient	 Global	 Impression	
of	Improvement	and	the	stress	incontinence	
subscale	of	the	Pelvic	Floor	Distress	Invento-
ry	to	measure	patient	satisfaction	and	urinary	
incontinence	symptoms.	
At	 3	 months,	 equivalent	 numbers	 of	
women	using	PFMT	and	a	pessary	(49%	and	
40%,	respectively;	P=.09)	reported	they	were	
“much	 better”	 or	 “very	 much	 better.”	 More	
women	in	the	PFMT	cohort	than	women	us-
ing	a	pessary	reported	resolution	of	 inconti-
nence	 symptoms	 at	 3	months	 (49%	 vs	 33%;	
P=.006),	and	satisfaction	with	treatment	(75%	
vs	 63%;	P=.02),	 but	 these	 differences	 disap-
peared	 at	 12	 months.	 Combination	 therapy	
wasn’t	superior	to	PFMT	alone.
Pelvic floor muscle training improves 
symptoms, especially with perseverance
A	 2011	 Cochrane	 review	 that	 compared	
women	receiving	PFMT	with	a	control	group	
(observed	but	not	 treated)	 found	that	PFMT	
moderately	 improved	 prolapse	 symptoms	
and	severity,	especially	following	6	months	of	
supervised	intervention.2	Investigators	evalu-
ated	4	trials,	(N=857),	including	3	with	fewer	
than	25	women	per	arm.	
Three	studies	found	that	PFMT	improved	
symptom	severity	and	manometric	measures.	
Although	 the	 authors	 couldn’t	 pool	 the	 data	
because	of	different	symptom	scoring	 instru-
ments,	typical	improvements	ranged	from	20%	
to	30%.	Two	trials	found	that	PFMT	increased	
the	 chance	 of	 improvement	 in	 POP	 stage	 by	
17%	(pooled	data,	 relative	 risk=.83;	95%	con-
fidence	 interval	 [CI],	 .71-.96).	PFMT	also	 im-
proved	 urinary	 outcomes	 (approximately	
30%	reduction	in	urinary	frequency	and	stress	
incontinence	 symptoms)	 in	 2	 of	 3	 trials	 and	
improved	 bowel	 symptoms	 in	 one	 trial	 (ap-
proximately	25%	to	30%	reduction).
Pessaries also relieve symptoms
A	 2013	 Cochrane	 Review	 seeking	 to	 deter-
mine	 the	 effectiveness	 of	 pessaries	 in	 POP,	
identified	 one	 RCT	 (crossover,	 3	 month,	
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references
multicenter,	 United	 States)	 that	 compared	
symptom	relief	and	change	in	life	impact	over	
baseline	for	134	women	(parous,	mean	age	61	
years,	range	30-89	years)	with	POP	stage	II	or	
greater	who	were	treated	with	ring	with	sup-
port	 or	Gellhorn	pessaries.3	 Sixty	 percent	 of	
patients	who	completed	the	study	(the	drop-
out	 rate	 was	 37%)	 reported	 symptom	 relief	
with	 both	 types	 of	 pessary.	 Outcomes	 were	
measured	 by	 multiple	 questionnaires	 and	
Likert	scales.	
Patients	 reported	 improved	 symptoms	
on	 both	 the	 Pelvic	 Organ	 Prolapse	 Distress	
Inventory	 (POPDI)	 and	 Pelvic	 Organ	 Pro-
lapse	 Impact	 Questionnaire	 (POPIQ)	 scales	
(P<.05	 for	 difference	 from	baseline	 on	 each	
scale,	 actual	 scores	 not	 reported).	The	 ring	
with	 support	 and	 Gellhorn	 pessaries	 didn’t	
produce	 different	 scores	 on	 either	 scale	
(POPDI,	P=.99;	POPIQ,	P=.29).
Untreated mild prolapse postmenopause 
usually doesn’t progress and may regress
A	cohort	of	412	postmenopausal	women	(ages	
≥50	years)	with	POP	who	were	observed,	but	
not	treated,	found	that	mild	POP	was	unlikely	
to	progress	and	sometimes	improved	sponta-
neously.4	Over	a	mean	follow-up	of	5.7	years,	
few	 women	 with	 grade	 1	 POP	 (prolapsed	
pelvic	 organs	 remaining	 within	 the	 vagina)	
progressed	 to	 grade	 2	 or	 3	 (probability	 of	
progression	for	women	with	cystoceles=.095,	
95%	CI,	.07-.13;	women	with	rectoceles=.135,	
95%	CI,	.09-.19;	and	women	with	uterine	pro-
lapse=.019,	95%	CI,	.0005-.099).	
Some	 women	 with	 grade	 1	 POP	 re-
gressed	 to	grade	0	 (probability	of	 regression	
for	women	with	cystoceles=.235,	95%	CI,	.19-
.28;	women	with	rectoceles=.22,	95%	CI,	.16-
.28;	 and	 women	 with	 uterine	 prolapse=.48,	
95%	CI,	0.34-.62).	Women	with	grades	2	and	
3	 POP	were	 less	 likely	 to	 regress	 to	 grade	 0	
(probability	 of	 regression	 for	 women	 with	
cystoceles=.093,	95%	CI,	.05-.14;	women	with	
rectoceles=.033,	95%	CI,	.011-.075;	and	wom-
en	with	uterine	prolapse=0,	95%	CI,	0-.37).		
One	flaw	of	this	study	was	that	the	wom-
en	 received	 hormone	 replacement	 therapy,	
which	 the	 investigators	 didn’t	 evaluate	 in-
dependently.	However,	 a	 2010	Cochrane	 re-
view	(2	small	trials,	one	meta-analysis)	found	
insufficient	 data	 to	 determine	whether	 hor-
mone	replacement	therapy	alters	POP.5
Recommendations 
The	 American	 College	 of	 Obstetricians	 and	
Gynecologists	Practice	Bulletin	on	POP	 rec-
ommends	the	following:6	
•			Pessaries	can	be	fitted	in	most	women	
with	 prolapse,	 regardless	 of	 prolapse	
stage	 (equivalent	 to	 grade)	 or	 site	 of	
predominant	prolapse.
•			Pessary	use	should	be	considered	be-
fore	 surgical	 intervention	 in	 women	
with	symptomatic	prolapse.
•			Women	with	 prolapse	who	 are	 asymp-
tomatic	 or	 mildly	 symptomatic	 can	 be	
observed	at	regular	intervals,	unless	new	
bothersome	symptoms	develop.											JFP
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